Historique de carrière de Gene Kim
Anciens postes connus de Gene Kim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2018 | 01/01/2020 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01/11/2013 | 01/05/2018 |
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | 01/01/2020 | - |
Formation de Gene Kim
| University of California, Los Angeles | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
